← FDA DRUG APPROVALS

FDA ANDA · ANDA080880

CHLOROQUINE PHOSPHATE

Sponsor: IMPAX LABS

APPLICATION
ANDA080880
TYPE
ANDA
ORIGINAL APPROVAL
1974-12-11
LATEST ACTION
2024-02-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CHLOROQUINE PHOSPHATEPrescription
CHLOROQUINE PHOSPHATE 250MG · TABLET · ORAL

Approval history

2024-02-02Labeling · Supplement 69 · standardAP
2023-07-24Labeling · Supplement 68 · standardAP
2022-05-03Labeling · Supplement 66 · standardAP
2022-03-17Labeling · Supplement 65 · standardAP
2020-04-30Labeling · Supplement 63 · standardAP
1997-07-18Manufacturing (CMC) · Supplement 45AP
1996-10-11Labeling · Supplement 43AP
1988-12-15Labeling · Supplement 40AP
1988-11-22Labeling · Supplement 39AP
1974-12-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →